Related Experiment Video
Updated: Jun 21, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Practical aspects of assessing toxicokinetics and toxicodynamics
D E Johnson1, R A Braeckman, G H Wolfgang
1Chiron Corporation, Emeryville, CA 94608-2916, USA. dale_johnson@cc.chiron.com
Abstract:
Designing and validating innovative high-throughput screening programs for toxicology requires an in-depth knowledge base on toxicokinetics and toxicodynamics (TK/TD), the two key elements of dose-response. This information is usually obtained from toxicology studies and mechanistically applied in the selection process for new drugs. Validating new toxicological endpoints and applying TK/TD modeling should enhance the predictability of such programs. This review looks at optimal approaches for collecting data and the four components of the TK/TD knowledge base; target specific exposure, toxicodynamics markers - with a focus on kidney, histomorphological correlates in target tissues, and human adverse event information. It is clear that new TK/TD approaches must be developed to create rational screening programs for the future.
Related Concept Videos
Toxicokinetics: Overview
Toxicity Testing in Animals
Measurement of Bioavailability: Pharmacodynamic Methods
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Measurement of Bioavailability: Pharmacokinetic Methods
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

